Compare LFST & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LFST | OPCH |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.5B |
| IPO Year | 2021 | 1996 |
| Metric | LFST | OPCH |
|---|---|---|
| Price | $11.38 | $21.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $9.83 | ★ $36.57 |
| AVG Volume (30 Days) | ★ 4.1M | 2.3M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 0.29 |
| Revenue | $1,424,285,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $17.18 | $7.21 |
| Revenue Next Year | $14.02 | $8.55 |
| P/E Ratio | ★ N/A | $76.66 |
| Revenue Growth | 13.85 | ★ 16.17 |
| 52 Week Low | $3.74 | $18.01 |
| 52 Week High | $11.62 | $36.80 |
| Indicator | LFST | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 71.04 | 50.10 |
| Support Level | $7.04 | $20.82 |
| Resistance Level | $11.62 | $22.42 |
| Average True Range (ATR) | 0.43 | 0.65 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 80.94 | 48.63 |
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.